The proportion of dysmorphic red cells (DRC) in the urinary sediment and their mean corpuscular volume (MCV) have been claimed to discriminate between glomerular and postglomerular sources of haematuria. To determine the diagnostic value of urinary DRC and MCV, we searched the literature and critically reviewed 21 published studies using a predetermined set of criteria for evaluation.
Introduction
Asymptomatic microscopic haematuria is a common finding with a reported prevalence of 5%' to 13%2 in the primary care setting. It may be associated with a wide range of conditions, from transient non-diseases, such as strenous exercise, to bladder cancer. Therefore, physicians frequently face the choice between the risk of missing a significant lesion in a patient with microhaematuria and the inconvenience of invasive examinations. 3 Determination of urinary red cell (RBC) shape may provide a solution to the problem. 4 This inexpensive and harmless test has been claimed to be diagnostic for glomerular haematuria and thus identify those who may be exempted from urological investigations. The presence of dysmorphic red cells (DRC) or of cells with low mean corpuscular volume (MCV) is believed to indicate glomerular bleeding; isomorphic red cells, or cells with a normal MCV are thought to originate from postglomerular sources. However, we know of no published reviews of the accuracy of these tests. How certain is the diagnosis of glomerular haematuria in a patient with DRC in the urine? How confident can one be that the source of bleeding is postglomerular given a finding of isomorphic red cells in the urine? What is the performance of the test in screening for serious urological disorders in various clinical settings?
The purpose of the following meta-analysis is to determine the reliability, sensitivity, specificity and predictive value of urinary DRC and MCV for glomerular disease. Reliability is defined as reproducibility upon repeated applications of the test on the same patient either by the same person (intraobserver reliability) or by two or more independent individuals (interobserver reliability). Test sensi-tivity is defined as true positive rate: of all patients with haematuria due to postglomerular disease, the proportion of those with DRC or low MCV. Test specificity is true negative rate: of those with haematuria due to postglomerular disease the proportion ofthose who excrete isomorphic cells or red cells with normal MCV. Test sensitivity and specificity should not be confused with the test's positive predictive value, which is defined as the proportion of patients with glomerular disease among all of those with DRC or a low MCV.
Methods
The literature was searched using Medline (1979 Medline ( -1990 ) and the reference sections of the reviewed articles. We screened all articles identified by the keyword 'haematuria' and found 35 studies of urinary red cell shape published since it was first used to identify the source of haematuria by Birch and Fairley in 1979 . Fourteen of these articles4-' were descriptive or technical reports, opinions, non-quantitative studies, or unrelated to the discrimination between glomerular and postglomerular haematuria. Each of the remaining 21"-3 was reviewed by both authors using the following criteria for evaluation:39 (a) description of the test procedure and of the criteria for the interpretation of its results; (b) determination of the reproducibility of the test results (precision) and of its interpretation (observer variation); (c) definition of the setting of the study, of the criteria for patient selection and ofthe degree and duration of haematuria in the studied patients; (d) 'blind' independent comparison with a gold standard of diagnosis; (e) determinations of the sensitivity and specificity of the test for glomerular disease; and (f) long-term consequences of the use of the test (follow-up of the patients with false-positive and false-negative results).
When possible, the sensitivity and specificity of urinary DRC and MCV for glomerular disease were calculated from the published data. The 95% confidence limits of the sensitivity and specificity were determined by the exact statistical method.'
This method accounts for the relatively small sample sizes and the fact that sensitivity and specificity estimates lie close to 1.0. Thus, the plausible ranges of these test characteristics' values are indicated to the reader, based on the available data.
Pooled estimates of sensitivity and specificity of both red cell morphology and MCV for glomerular haematuria were calculated using the method of weighted averages. The predictive value of a given test result, e.g. the (post-test) probability of urological disease given a normal MCV, was determined using Bayes' rule39 and was based on the disease prevalences and the calculated sensitivities and specificities.
Results

Test procedures and interpretation
Two methods have been used to determine urinary red cell shape: the first one consists of determination of the proportion of DRC by phase contrast microscopy (for example, ref. 19 There are also considerable differences in the criteria of interpretation of urinary MCV. Most authors have interpreted a unimodal red cell distribution with a MCV of 50 fL or less and 80 fiL or more as indicating glomerular and post-glomerular sources of bleeding, respectively; bimodal MCV histograms have been interpreted as 'mixed'.2",22 '30 Others have used 75 fL37 and 72 fL38 as cut-off values, while still other authors have claimed that a urinary-blood MCV difference of 0 or less is a better indicator for a glomerular source of haematuria than the absolute MCV value of urinary red cells.3
Reliability
None of the reviewed studies reported estimates of intraobserver variability in interpreting urinary DRC. Interobserver variability was reported in four studies. One of them stated in general terms that the disagreement between observers did not exceed the expected intraobserver variability. 24 In two studies, independent observers disagreed on the source ofhaematuria in 10%2°and 25%27 of the specimens. The fourth study reported a correlation coefficient of0.85 between the proportions of DRC reported by two observers. 33 The reproducibility of urinary red cell MCV was examined in two studies.'6'35 One of them found almost identical MCV histograms in different urine samples of the same individual. 35 The second'6 reported that MCV declined with increasing dilutions of the same red cell sample, and that urinary debris interfered with MCV determinations at low red cell concentrations.
Setting, patient selection and degree ofhaematuria All studies were carried out in referred inpatients'824 or outpatients,2533 without defining the criteria of patient referral by the primary care physician, or those of patient selection by the consultant. Two authors28,32 reported the inclusion criterion of recurrent haematuria for 3-6 months. The degree of haematuria was either not reported, 20-2429.30,32 or defined as more than 3,000-10,000 RBC/ml,19'27'28,39 more than 4 RBC/ microscopic high power field,24 or as varying from micro-to gross-haematuria.'8'25 '26,3' Comparison with a gold standard ofdiagnosis Of all cases with haematuria, the proportion of those in whom a definitive diagnosis was reached varied between 14%3°and 94%24 (Table I) . Once a cause for haematuria was detected, the investigation was discontinued; it is therefore uncertain, whether the 'mixed haematuria's were produced by two coexisting sources of bleeding or represent a variant originating from a single source. With one exception,4' all studies were restricted to those patients in whom the cause of haematuria could be established by kidney biopsies or the presence of red cell casts in cases of glomerular disease, and by cystoscopy and/or contrast urography in cases of postglomerular lesions. In all studies the urinary red cell shape was interpreted by observers who were blinded to the diagnosis. There was a wider variation of the data derived from studies of urinary DRC than those derived from urinary MCV. The weighted averages and 95% confidence intervals derived from determinations of urinary DRC in outpatients were 0.84 (0.80-0.86) for sensitivity and 0.92 (0.89-0.94) for specificity; those derived from MCV studies of outpatients were 1.0 (0.97-1.0) for sensitivity and 0.80(0.71-0.87) for specificity (Tables II and III) . As expected the sensitivity ofthe test increased with a corresponding decline in its specificity when the finding of 'mixed' haematuria was assumed to indicate glomerular bleeding.
Calculation ofthe predictive value ofurinary red cell shape
The predictive value of any test depends on its sensitivity and specificity, but also on the prevalence of the disease in question in the population from which the patient is drawn, the so-called 'pretest probability' or prior probability of disease'. 39 The pooled sensitivity of a low urinary red cell MCV for glomerular disease was 1.0, while its specificity was 0.87 (Table III) . The prevalence of postglomerular (urological) disorders in the reviewed series varied from 26 to 72% (Table I) .
After applying Bayes' rule,39 a finding of low MCV haematuria would reduce the probability of urological disease to 4 and 25%, respectively. In other words, the source of haematuria may turn out to be urological in as many as 4-25% of referred patients with low MCV haematuria.
Urinary red cell shape in normal subjects Asymptomatic and healthy individuals have been shown to excrete up to 3,0008 and 8,000'9 red blood cells per ml urine. The red cells excreted by healthy controls were reported to be of dysmorphic appearance. 8 19 However, in another study of normal controls Fasset et al.8 reported that 'many (normal) subjects had distorted cells similar to those seen in patients with glomerulonephritis, but many also had non-glomerular cells'. Physical exercise in healthy adults is known to be associated with urinary abnormalities, including haematuria.8'9 Urinary red cell morphology after exercise has been reported to be of dysmorphic8'9 and isomorphic'7 types.
Discussion
The presented survey of the diagnostic value of urinary red cell shape identified several limitations, which at present preclude its application as a definitive discriminating test between glomerular and postglomerular haematuria. First, all studies were carried out on patients who passed the triple filter of referral by the primary care physician, selection by the consultant and eventual establishment of a certain diagnosis. These were highly selected patients who probably had recurrent rather than transient haematuria, or with more severe bleeding rather than the whole spectrum haematuria. In general, diagnostic tests perform better in patients with more severe disease.42 Therefore, the calculated averages of the test properties are appropriate for referral centres, but may not be applicable in the primary care setting.
Second, the uncertain inter-and intraobserver agreement in identifying DRC and the variability in the proportions of DRC used as a cut-off between glomerular and non-glomerular bleeding indicate that the reliability (reproducibility) of the test is, at best, conditional on expertise. Urinary red cell MCV determinations are less affected by subjective interpretations and their sensitivity and specificity are higher and more consistent than those of urinary DRC. However, MCV determinations may not be reliable in patients with low-grade haematuria. 16, 35 Even ignoring the poor reliability of urinary red cell shape determinations, the presented survey indicates that a finding of low MCV haematuria in a referred patient would reduce the probability, but group.bmj.com on October 14, 2017 -Published by http://pmj.bmj.com/ Downloaded from not exclude the possibility of urological disease. These limitations ofthe test were evident also in the only study of the long-term consequences ofits use. Schramek and his associates4' studied 316 referred patients with symptomless microhaematuria, 123 of whom excreted isomorphic red cells. Of these 123 patients, postglomerular sources of bleeding, including 10 urothelial malignancies, were identified in 104. The remaining 193 patients with dysmorphic haematuria had no further investigations, but were carefully followed for at least 2 years. Bladder cancer and nephrolithiasis were diagnosed in two patients 2 and 4 years later, respectively. The authors concluded that microscopic analysis of urinary erythrocyte morphology is '... an effective method for identifying patients with symptomless microhaematuria needing specific diagnostic investigation'. Yet, two urological lesions were diagnosed in patients initially thought to have had glomerular haematuria. These lesions may have been a late development; alternatively, they may have been missed by the examination of urinary morphology.
Despite its limited value in referred patients, urinary red cell MCV could be useful in the primary care setting, where the prevalence of urological disorders is lower than in referral centres. Given a low pretest probability, the test could identify persons with symptomless microhaematuria who are at a still lower risk of urological disorders and therefore may be exempted from immediate investigations. However, urinary MCV has never been studied in the primary care setting, and its diagnostic value in persons with incidentally detected low-grade haematuria is uncertain.
We conclude that at present the use of urinary red cell shape as an indicator of the source of haematuria is in need of further experimental development and evaluation. In order to improve their reproducibility the criteria for identification of DRC must be rigidly standardized and the cut-off values separating between glomerular and postglomerular bleeding should be redefined in order to maximize specificity. The reliability of MCV determinations in cases of microhaematuria will have to be reassessed. Only then will it be possible to evaluate whether the test's sensitivity, specificity and predictive value warrant its use in the investigation of haematuria.
